Page last updated: 2024-08-21

benzoxazoles and Chemical Dependence

benzoxazoles has been researched along with Chemical Dependence in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mediavilla, C; Risco, S	1
Cannella, N; Ciccocioppo, R; Economidou, D; Heilig, M; Kallupi, M; Massi, M; Stopponi, S	1
Gyertyán, I; Kiss, B; Román, V; Sághy, K; Szombathelyi, Z	1

Reviews

1 review(s) available for benzoxazoles and Chemical Dependence

Article	Year
[Orexin: clinical and therapeutic implications]. Revista de neurologia, 2014, Feb-01, Volume: 58, Issue:3 Topics: Animals; Arousal; Azepines; Benzoxazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding and Eating Disorders; Feeding Behavior; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mice, Transgenic; Motor Activity; Naphthyridines; Narcolepsy; Neuropeptides; Obesity; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Substance-Related Disorders; Triazoles; Urea	2014

Article

Year

[Orexin: clinical and therapeutic implications].

Revista de neurologia, 2014, Feb-01, Volume: 58, Issue:3

Topics: Animals; Arousal; Azepines; Benzoxazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding and Eating Disorders; Feeding Behavior; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mice, Transgenic; Motor Activity; Naphthyridines; Narcolepsy; Neuropeptides; Obesity; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Substance-Related Disorders; Triazoles; Urea

2014

Other Studies

2 other study(ies) available for benzoxazoles and Chemical Dependence

Article	Year
Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:9 Topics: Alcohol Drinking; Analysis of Variance; Animals; Benzoxazoles; Central Nervous System Depressants; Conditioning, Classical; Cues; Disease Models, Animal; Ethanol; Hypothalamus; Male; Naphthyridines; Neuropeptides; Orexin Receptors; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Self Administration; Substance-Related Disorders; Urea	2009
Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats. Psychopharmacology, 2013, Volume: 226, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Secondary Prevention; Substance-Related Disorders	2013

Article

Year

Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:9

Topics: Alcohol Drinking; Analysis of Variance; Animals; Benzoxazoles; Central Nervous System Depressants; Conditioning, Classical; Cues; Disease Models, Animal; Ethanol; Hypothalamus; Male; Naphthyridines; Neuropeptides; Orexin Receptors; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Self Administration; Substance-Related Disorders; Urea

2009

Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.

Psychopharmacology, 2013, Volume: 226, Issue:2

Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Secondary Prevention; Substance-Related Disorders

2013